{"transactions":[{"id":1020977,"issuer":{"id":9910,"kind":"organization","name":"Palomino Laboratories Inc."},"owners":[{"id":74384,"kind":"person","name":"Tu Jason","position":1,"cik":"0002089678","reported_name":"Tu Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Warrants","published_at":"2025-10-09T15:31:42.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":true,"shares":41667,"price":1.2,"value":50000.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Per the terms of an Agreement and Plan of Merger, dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., \"Pre-Merger Palomino\"). Mr. Tu, as a shareholder of Pre-Merger Palomino, received 41,667 shares of common stock, par value $0.0001 per share, of Issuer (\"Common Stock\") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Tu converted his SAFEs into 41,667 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Per the terms of an Agreement and Plan of Merger, dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., \"Pre-Merger Palomino\"). Mr. Tu, as a shareholder of Pre-Merger Palomino, received 41,667 shares of common stock, par value $0.0001 per share, of Issuer (\"Common Stock\") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Tu converted his SAFEs into 41,667 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement)."}],"balance_after":41667,"derivative":{"exercise_price":1.5,"exercise_date":"2025-09-29","underlying":"Common Stock","underlying_shares":41667},"source":{"system":"sec-edgar","filing":"0001493152-25-017568","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2089678/000149315225017568/ownership.xml","form_type":"4"}},{"id":1020976,"issuer":{"id":9910,"kind":"organization","name":"Palomino Laboratories Inc."},"owners":[{"id":74384,"kind":"person","name":"Tu Jason","position":1,"cik":"0002089678","reported_name":"Tu Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-10-09T15:31:42.000Z","date":"2025-09-29","kind":"other","planned":false,"acquired":true,"shares":83334,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Per the terms of an Agreement and Plan of Merger, dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., \"Pre-Merger Palomino\"). Mr. Tu, as a shareholder of Pre-Merger Palomino, received 41,667 shares of common stock, par value $0.0001 per share, of Issuer (\"Common Stock\") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Tu converted his SAFEs into 41,667 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Per the terms of an Agreement and Plan of Merger, dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., \"Pre-Merger Palomino\"). Mr. Tu, as a shareholder of Pre-Merger Palomino, received 41,667 shares of common stock, par value $0.0001 per share, of Issuer (\"Common Stock\") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Tu converted his SAFEs into 41,667 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement)."}],"balance_after":125001,"source":{"system":"sec-edgar","filing":"0001493152-25-017568","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2089678/000149315225017568/ownership.xml","form_type":"4"}}]}